0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Proteomics Technology Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-26X16813
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Proteomics Technology Service Market Research Report 2024
BUY CHAPTERS

Global Proteomics Technology Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26X16813
Report
November 2025
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Proteomics Technology Service Market

The global Proteomics Technology Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Proteomics Technology Service refers to providing relevant technical support and services required for proteomics research to scientific researchers, aiming to improve research in the fields of protein profiling, protein identification, protein dynamics, functionality and subcellular localization. This service covers a variety of technologies, including but not limited to protein separation and purification technology, identification and sequencing technology, quantitative technology, and bioinformatics analysis technology. In addition, mass spectrometry-based proteomics analysis services are also an important part of it.
Regarding future development trends, Proteomics Technology Service will focus more on high-throughput analysis to meet the needs of large-scale sample analysis. High-throughput technologies, such as protein chip technology and parallel reaction technology, make it possible to detect thousands of proteins at the same time, which will accelerate the process of biological drug development.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Proteomics Technology Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Proteomics Technology Service Market Report

Report Metric Details
Report Name Proteomics Technology Service Market
Segment by Type
  • Protein Fractionation
  • Peptide Fractionation
  • Protein Mass Spectrometry
  • Protein Identification
  • Others
Segment by Application
  • Biomarker Discovery
  • Disease Research
  • Drug Discovery and Development
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alamar Bioscience, Applied Biomics, AxisPharm, BGI, Biocompare, Tymora Analytical, Biogenity, Biognosys, Cell Signaling Technology, Charles River Laboratories, Creative Proteomics, Crown Bioscience, Labtoo, Proteome Sciences, RayBiotech, SGS Korea, System Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Proteomics Technology Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Proteomics Technology Service Market report?

Ans: The main players in the Proteomics Technology Service Market are Alamar Bioscience, Applied Biomics, AxisPharm, BGI, Biocompare, Tymora Analytical, Biogenity, Biognosys, Cell Signaling Technology, Charles River Laboratories, Creative Proteomics, Crown Bioscience, Labtoo, Proteome Sciences, RayBiotech, SGS Korea, System Biosciences

What are the Application segmentation covered in the Proteomics Technology Service Market report?

Ans: The Applications covered in the Proteomics Technology Service Market report are Biomarker Discovery, Disease Research, Drug Discovery and Development, Others

What are the Type segmentation covered in the Proteomics Technology Service Market report?

Ans: The Types covered in the Proteomics Technology Service Market report are Protein Fractionation, Peptide Fractionation, Protein Mass Spectrometry, Protein Identification, Others

1 Study Coverage
1.1 Introduction to Proteomics Technology Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Proteomics Technology Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Protein Fractionation
1.2.3 Peptide Fractionation
1.2.4 Protein Mass Spectrometry
1.2.5 Protein Identification
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Proteomics Technology Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomarker Discovery
1.3.3 Disease Research
1.3.4 Drug Discovery and Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Proteomics Technology Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Proteomics Technology Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Proteomics Technology Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Proteomics Technology Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Protein Fractionation Market Size by Players
3.3.2 Peptide Fractionation Market Size by Players
3.3.3 Protein Mass Spectrometry Market Size by Players
3.3.4 Protein Identification Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Proteomics Technology Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Proteomics Technology Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Proteomics Technology Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Proteomics Technology Service Market Size by Type (2020-2031)
6.4 North America Proteomics Technology Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Proteomics Technology Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Proteomics Technology Service Market Size by Type (2020-2031)
7.4 Europe Proteomics Technology Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Proteomics Technology Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Proteomics Technology Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Proteomics Technology Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Proteomics Technology Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Proteomics Technology Service Market Size by Type (2020-2031)
9.4 Central and South America Proteomics Technology Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Proteomics Technology Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Proteomics Technology Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Proteomics Technology Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Proteomics Technology Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Alamar Bioscience
11.1.1 Alamar Bioscience Corporation Information
11.1.2 Alamar Bioscience Business Overview
11.1.3 Alamar Bioscience Proteomics Technology Service Product Features and Attributes
11.1.4 Alamar Bioscience Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.1.5 Alamar Bioscience Proteomics Technology Service Revenue by Product in 2024
11.1.6 Alamar Bioscience Proteomics Technology Service Revenue by Application in 2024
11.1.7 Alamar Bioscience Proteomics Technology Service Revenue by Geographic Area in 2024
11.1.8 Alamar Bioscience Proteomics Technology Service SWOT Analysis
11.1.9 Alamar Bioscience Recent Developments
11.2 Applied Biomics
11.2.1 Applied Biomics Corporation Information
11.2.2 Applied Biomics Business Overview
11.2.3 Applied Biomics Proteomics Technology Service Product Features and Attributes
11.2.4 Applied Biomics Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.2.5 Applied Biomics Proteomics Technology Service Revenue by Product in 2024
11.2.6 Applied Biomics Proteomics Technology Service Revenue by Application in 2024
11.2.7 Applied Biomics Proteomics Technology Service Revenue by Geographic Area in 2024
11.2.8 Applied Biomics Proteomics Technology Service SWOT Analysis
11.2.9 Applied Biomics Recent Developments
11.3 AxisPharm
11.3.1 AxisPharm Corporation Information
11.3.2 AxisPharm Business Overview
11.3.3 AxisPharm Proteomics Technology Service Product Features and Attributes
11.3.4 AxisPharm Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.3.5 AxisPharm Proteomics Technology Service Revenue by Product in 2024
11.3.6 AxisPharm Proteomics Technology Service Revenue by Application in 2024
11.3.7 AxisPharm Proteomics Technology Service Revenue by Geographic Area in 2024
11.3.8 AxisPharm Proteomics Technology Service SWOT Analysis
11.3.9 AxisPharm Recent Developments
11.4 BGI
11.4.1 BGI Corporation Information
11.4.2 BGI Business Overview
11.4.3 BGI Proteomics Technology Service Product Features and Attributes
11.4.4 BGI Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.4.5 BGI Proteomics Technology Service Revenue by Product in 2024
11.4.6 BGI Proteomics Technology Service Revenue by Application in 2024
11.4.7 BGI Proteomics Technology Service Revenue by Geographic Area in 2024
11.4.8 BGI Proteomics Technology Service SWOT Analysis
11.4.9 BGI Recent Developments
11.5 Biocompare
11.5.1 Biocompare Corporation Information
11.5.2 Biocompare Business Overview
11.5.3 Biocompare Proteomics Technology Service Product Features and Attributes
11.5.4 Biocompare Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.5.5 Biocompare Proteomics Technology Service Revenue by Product in 2024
11.5.6 Biocompare Proteomics Technology Service Revenue by Application in 2024
11.5.7 Biocompare Proteomics Technology Service Revenue by Geographic Area in 2024
11.5.8 Biocompare Proteomics Technology Service SWOT Analysis
11.5.9 Biocompare Recent Developments
11.6 Tymora Analytical
11.6.1 Tymora Analytical Corporation Information
11.6.2 Tymora Analytical Business Overview
11.6.3 Tymora Analytical Proteomics Technology Service Product Features and Attributes
11.6.4 Tymora Analytical Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.6.5 Tymora Analytical Recent Developments
11.7 Biogenity
11.7.1 Biogenity Corporation Information
11.7.2 Biogenity Business Overview
11.7.3 Biogenity Proteomics Technology Service Product Features and Attributes
11.7.4 Biogenity Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.7.5 Biogenity Recent Developments
11.8 Biognosys
11.8.1 Biognosys Corporation Information
11.8.2 Biognosys Business Overview
11.8.3 Biognosys Proteomics Technology Service Product Features and Attributes
11.8.4 Biognosys Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.8.5 Biognosys Recent Developments
11.9 Cell Signaling Technology
11.9.1 Cell Signaling Technology Corporation Information
11.9.2 Cell Signaling Technology Business Overview
11.9.3 Cell Signaling Technology Proteomics Technology Service Product Features and Attributes
11.9.4 Cell Signaling Technology Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.9.5 Cell Signaling Technology Recent Developments
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Corporation Information
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories Proteomics Technology Service Product Features and Attributes
11.10.4 Charles River Laboratories Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative Proteomics
11.11.1 Creative Proteomics Corporation Information
11.11.2 Creative Proteomics Business Overview
11.11.3 Creative Proteomics Proteomics Technology Service Product Features and Attributes
11.11.4 Creative Proteomics Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.11.5 Creative Proteomics Recent Developments
11.12 Crown Bioscience
11.12.1 Crown Bioscience Corporation Information
11.12.2 Crown Bioscience Business Overview
11.12.3 Crown Bioscience Proteomics Technology Service Product Features and Attributes
11.12.4 Crown Bioscience Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.12.5 Crown Bioscience Recent Developments
11.13 Labtoo
11.13.1 Labtoo Corporation Information
11.13.2 Labtoo Business Overview
11.13.3 Labtoo Proteomics Technology Service Product Features and Attributes
11.13.4 Labtoo Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.13.5 Labtoo Recent Developments
11.14 Proteome Sciences
11.14.1 Proteome Sciences Corporation Information
11.14.2 Proteome Sciences Business Overview
11.14.3 Proteome Sciences Proteomics Technology Service Product Features and Attributes
11.14.4 Proteome Sciences Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.14.5 Proteome Sciences Recent Developments
11.15 RayBiotech
11.15.1 RayBiotech Corporation Information
11.15.2 RayBiotech Business Overview
11.15.3 RayBiotech Proteomics Technology Service Product Features and Attributes
11.15.4 RayBiotech Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.15.5 RayBiotech Recent Developments
11.16 SGS Korea
11.16.1 SGS Korea Corporation Information
11.16.2 SGS Korea Business Overview
11.16.3 SGS Korea Proteomics Technology Service Product Features and Attributes
11.16.4 SGS Korea Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.16.5 SGS Korea Recent Developments
11.17 System Biosciences
11.17.1 System Biosciences Corporation Information
11.17.2 System Biosciences Business Overview
11.17.3 System Biosciences Proteomics Technology Service Product Features and Attributes
11.17.4 System Biosciences Proteomics Technology Service Revenue and Gross Margin (2020-2025)
11.17.5 System Biosciences Recent Developments
12 Proteomics Technology ServiceIndustry Chain Analysis
12.1 Proteomics Technology Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Proteomics Technology Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Proteomics Technology Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Proteomics Technology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Proteomics Technology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Proteomics Technology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Proteomics Technology Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Proteomics Technology Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Proteomics Technology Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Proteomics Technology Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Proteomics Technology Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomics Technology Service as of 2024)
 Table 11. Global Proteomics Technology Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Proteomics Technology Service Companies Headquarters
 Table 13. Global Proteomics Technology Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Proteomics Technology Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Proteomics Technology Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Proteomics Technology Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Proteomics Technology Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Proteomics Technology Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Proteomics Technology Service Growth Accelerators and Market Barriers
 Table 25. North America Proteomics Technology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Proteomics Technology Service Growth Accelerators and Market Barriers
 Table 27. Europe Proteomics Technology Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Proteomics Technology Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Proteomics Technology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Proteomics Technology Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Proteomics Technology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Proteomics Technology Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Proteomics Technology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Alamar Bioscience Corporation Information
 Table 35. Alamar Bioscience Description and Major Businesses
 Table 36. Alamar Bioscience Product Features and Attributes
 Table 37. Alamar Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Alamar Bioscience Revenue Proportion by Product in 2024
 Table 39. Alamar Bioscience Revenue Proportion by Application in 2024
 Table 40. Alamar Bioscience Revenue Proportion by Geographic Area in 2024
 Table 41. Alamar Bioscience Proteomics Technology Service SWOT Analysis
 Table 42. Alamar Bioscience Recent Developments
 Table 43. Applied Biomics Corporation Information
 Table 44. Applied Biomics Description and Major Businesses
 Table 45. Applied Biomics Product Features and Attributes
 Table 46. Applied Biomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Applied Biomics Revenue Proportion by Product in 2024
 Table 48. Applied Biomics Revenue Proportion by Application in 2024
 Table 49. Applied Biomics Revenue Proportion by Geographic Area in 2024
 Table 50. Applied Biomics Proteomics Technology Service SWOT Analysis
 Table 51. Applied Biomics Recent Developments
 Table 52. AxisPharm Corporation Information
 Table 53. AxisPharm Description and Major Businesses
 Table 54. AxisPharm Product Features and Attributes
 Table 55. AxisPharm Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. AxisPharm Revenue Proportion by Product in 2024
 Table 57. AxisPharm Revenue Proportion by Application in 2024
 Table 58. AxisPharm Revenue Proportion by Geographic Area in 2024
 Table 59. AxisPharm Proteomics Technology Service SWOT Analysis
 Table 60. AxisPharm Recent Developments
 Table 61. BGI Corporation Information
 Table 62. BGI Description and Major Businesses
 Table 63. BGI Product Features and Attributes
 Table 64. BGI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. BGI Revenue Proportion by Product in 2024
 Table 66. BGI Revenue Proportion by Application in 2024
 Table 67. BGI Revenue Proportion by Geographic Area in 2024
 Table 68. BGI Proteomics Technology Service SWOT Analysis
 Table 69. BGI Recent Developments
 Table 70. Biocompare Corporation Information
 Table 71. Biocompare Description and Major Businesses
 Table 72. Biocompare Product Features and Attributes
 Table 73. Biocompare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Biocompare Revenue Proportion by Product in 2024
 Table 75. Biocompare Revenue Proportion by Application in 2024
 Table 76. Biocompare Revenue Proportion by Geographic Area in 2024
 Table 77. Biocompare Proteomics Technology Service SWOT Analysis
 Table 78. Biocompare Recent Developments
 Table 79. Tymora Analytical Corporation Information
 Table 80. Tymora Analytical Description and Major Businesses
 Table 81. Tymora Analytical Product Features and Attributes
 Table 82. Tymora Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Tymora Analytical Recent Developments
 Table 84. Biogenity Corporation Information
 Table 85. Biogenity Description and Major Businesses
 Table 86. Biogenity Product Features and Attributes
 Table 87. Biogenity Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Biogenity Recent Developments
 Table 89. Biognosys Corporation Information
 Table 90. Biognosys Description and Major Businesses
 Table 91. Biognosys Product Features and Attributes
 Table 92. Biognosys Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Biognosys Recent Developments
 Table 94. Cell Signaling Technology Corporation Information
 Table 95. Cell Signaling Technology Description and Major Businesses
 Table 96. Cell Signaling Technology Product Features and Attributes
 Table 97. Cell Signaling Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Cell Signaling Technology Recent Developments
 Table 99. Charles River Laboratories Corporation Information
 Table 100. Charles River Laboratories Description and Major Businesses
 Table 101. Charles River Laboratories Product Features and Attributes
 Table 102. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Charles River Laboratories Recent Developments
 Table 104. Creative Proteomics Corporation Information
 Table 105. Creative Proteomics Description and Major Businesses
 Table 106. Creative Proteomics Product Features and Attributes
 Table 107. Creative Proteomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Creative Proteomics Recent Developments
 Table 109. Crown Bioscience Corporation Information
 Table 110. Crown Bioscience Description and Major Businesses
 Table 111. Crown Bioscience Product Features and Attributes
 Table 112. Crown Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Crown Bioscience Recent Developments
 Table 114. Labtoo Corporation Information
 Table 115. Labtoo Description and Major Businesses
 Table 116. Labtoo Product Features and Attributes
 Table 117. Labtoo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Labtoo Recent Developments
 Table 119. Proteome Sciences Corporation Information
 Table 120. Proteome Sciences Description and Major Businesses
 Table 121. Proteome Sciences Product Features and Attributes
 Table 122. Proteome Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Proteome Sciences Recent Developments
 Table 124. RayBiotech Corporation Information
 Table 125. RayBiotech Description and Major Businesses
 Table 126. RayBiotech Product Features and Attributes
 Table 127. RayBiotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. RayBiotech Recent Developments
 Table 129. SGS Korea Corporation Information
 Table 130. SGS Korea Description and Major Businesses
 Table 131. SGS Korea Product Features and Attributes
 Table 132. SGS Korea Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. SGS Korea Recent Developments
 Table 134. System Biosciences Corporation Information
 Table 135. System Biosciences Description and Major Businesses
 Table 136. System Biosciences Product Features and Attributes
 Table 137. System Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. System Biosciences Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Proteomics Technology Service Product Picture
 Figure 2. Global Proteomics Technology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Protein Fractionation Product Picture
 Figure 4. Peptide Fractionation Product Picture
 Figure 5. Protein Mass Spectrometry Product Picture
 Figure 6. Protein Identification Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Proteomics Technology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Biomarker Discovery
 Figure 10. Disease Research
 Figure 11. Drug Discovery and Development
 Figure 12. Others
 Figure 13. Proteomics Technology Service Report Years Considered
 Figure 14. Global Proteomics Technology Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Proteomics Technology Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Proteomics Technology Service Revenue Market Share by Region (2020-2031)
 Figure 18. Global Proteomics Technology Service Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Protein Fractionation Revenue Market Share by Player in 2024
 Figure 21. Peptide Fractionation Revenue Market Share by Player in 2024
 Figure 22. Protein Mass Spectrometry Revenue Market Share by Player in 2024
 Figure 23. Protein Identification Revenue Market Share by Player in 2024
 Figure 24. Others Revenue Market Share by Player in 2024
 Figure 25. Global Proteomics Technology Service Revenue Market Share by Type (2020-2031)
 Figure 26. Global Proteomics Technology Service Revenue Market Share by Application (2020-2031)
 Figure 27. North America Proteomics Technology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Players Proteomics Technology Service Revenue (US$ Million) in 2024
 Figure 29. North America Proteomics Technology Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Proteomics Technology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 31. US Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 32. Canada Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 33. Mexico Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 34. Europe Proteomics Technology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 35. Europe Top 5 Players Proteomics Technology Service Revenue (US$ Million) in 2024
 Figure 36. Europe Proteomics Technology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 37. Europe Proteomics Technology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 38. Germany Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 39. France Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 40. U.K. Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 41. Italy Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Russia Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Proteomics Technology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Top 8 Players Proteomics Technology Service Revenue (US$ Million) in 2024
 Figure 45. Asia-Pacific Proteomics Technology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Asia-Pacific Proteomics Technology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Indonesia Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Japan Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 49. South Korea Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Australia Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 51. India Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Indonesia Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Vietnam Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Malaysia Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 55. Philippines Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 56. Singapore Proteomics Technology Service Revenue (2020-2031) & (US$ Million)
 Figure 57. Central and South America Proteomics Technology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Central and South America Top 5 Players Proteomics Technology Service Revenue (US$ Million) in 2024
 Figure 59. Central and South America Proteomics Technology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Central and South America Proteomics Technology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. Brazil Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Argentina Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Middle East and Africa Proteomics Technology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Middle East and Africa Top 5 Players Proteomics Technology Service Revenue (US$ Million) in 2024
 Figure 65. South America Proteomics Technology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Middle East and Africa Proteomics Technology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 67. GCC Countries Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Israel Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 69. Egypt Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 70. South Africa Proteomics Technology Service Revenue (2020-2025) & (US$ Million)
 Figure 71. Proteomics Technology Service Industry Chain Mapping
 Figure 72. Channels of Distribution (Direct Vs Distribution)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension